Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
Genmab announces results of ofatumumab Phase II study in multiple sclerosis
Novantrone (mitoxantrone HCl) Injection February 2009
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.
Keystone Symposium: Multiple Sclerosis
Immune competence after alemtuzumab treatment of multiple sclerosis.
Incidence of infusion-associated reactions with rituximab for treating multiple sclerosis: a retrospective analysis of patients treated at a US centre.
Antioxidant properties of the triaminopyridine, flupirtine.
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis.
Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study.
Adaptive myelination from fish to man.
Opinion: Sex inclusion in basic research drives discovery.
One can prevent post-partum MS relapses by exclusive breast feeding: no.
Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity.
Incorporating Alcohol Pharmacotherapies Into Medical Practice
Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study.
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
Anti-JCV antibody levels in serum or plasma further define risk of natalizumab-associated PML.
Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.
Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE® 20 mg/mL Case and Remand for Further Review
Interferon-beta in pediatric multiple sclerosis patients: safety in short-term prescription.
Regulation of prefrontal cortex myelination by the microbiota.
PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.
The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Chemotactic Cytokines: Gordon Research Conference on Molecular and Cellular Mechanisms in Health and Disease

Pages